Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized phase II/III study of adverse events between sequential (SEQ) versus simultaneous integrated boost (SIB) intensity modulated radiation therapy (IMRT) in nasopharyngeal carcinoma; preliminary result on acute adverse events.
Songthong AP, Kannarunimit D, Chakkabat C, Lertbutsayanukul C. Songthong AP, et al. Among authors: kannarunimit d. Radiat Oncol. 2015 Aug 8;10:166. doi: 10.1186/s13014-015-0472-y. Radiat Oncol. 2015. PMID: 26253488 Free PMC article. Clinical Trial.
Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review.
Ahn MJ, D'Cruz A, Vermorken JB, Chen JP, Chitapanarux I, Dang HQ, Guminski A, Kannarunimit D, Lin TY, Ng WT, Park KU, Chan AT. Ahn MJ, et al. Among authors: kannarunimit d, d cruz a. Oral Oncol. 2016 Feb;53:10-6. doi: 10.1016/j.oraloncology.2015.11.019. Epub 2015 Dec 19. Oral Oncol. 2016. PMID: 26712252 Free article. Review.
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic.
Lee VH, Adham M, Ben Kridis W, Bossi P, Chen MY, Chitapanarux I, Gregoire V, Hao SP, Ho C, Ho GF, Kannarunimit D, Kwong DL, Lam KO, Lam WKJ, Le QT, Lee AW, Lee NY, Leung TW, Licitra L, Lim DW, Lin JC, Loh KS, Lou PJ, Machiels JP, Mai HQ, Mesía R, Ng WT, Ngan RK, Tay JK, Tsang RK, Tong CC, Wang HM, Wee JT. Lee VH, et al. Among authors: kannarunimit d. Lancet Oncol. 2022 Dec;23(12):e544-e551. doi: 10.1016/S1470-2045(22)00505-8. Lancet Oncol. 2022. PMID: 36455583 Free PMC article. Review.
A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma.
Lertbutsayanukul C, Prayongrat A, Kannarunimit D, Chakkabat C, Netsawang B, Kitpanit S. Lertbutsayanukul C, et al. Among authors: kannarunimit d. Strahlenther Onkol. 2018 May;194(5):375-385. doi: 10.1007/s00066-017-1251-5. Epub 2018 Jan 4. Strahlenther Onkol. 2018. PMID: 29302704 Clinical Trial. English.
Validation of previously reported predictors for radiation-induced hypothyroidism in nasopharyngeal cancer patients treated with intensity-modulated radiation therapy, a post hoc analysis from a Phase III randomized trial.
Lertbutsayanukul C, Kitpanit S, Prayongrat A, Kannarunimit D, Netsawang B, Chakkabat C. Lertbutsayanukul C, et al. Among authors: kannarunimit d. J Radiat Res. 2018 Jul 1;59(4):446-455. doi: 10.1093/jrr/rry036. J Radiat Res. 2018. PMID: 29750261 Free PMC article. Clinical Trial.
28 results